Device Trial Radar · NCT03164551
TICON-Day 3, Time Lapse Versus Conventional Method in Day 3 Embryo Culture and Assessment
Last checked: Nov 19, 2026Latest source record: Dec 2, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
408
Actual
Start
Apr 16, 2018
Primary completion
Nov 20, 2019
Study completion Nov 20, 2019
Sponsor
- Lead sponsor
- Merck KGaA, Darmstadt, GermanyNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 23, 2017
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 40 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The main purpose of the study was to evaluate the overall clinical value of GERI+ as an integrated embryo culture and assessment system, providing an undisturbed culture environment, continuous monitoring of embryo development and automated scoring using a predictive algorithm.
Conditions
- Infertility
Interventions
GERI+ incubatorDevice
The embryo culture of consented participants were carried out in GERI+ incubator for both bright-field and dark-field time lapse monitoring until Day 3 of embryo culture. On Day 3, all embryos were reviewed firstly by GERI Assess software, using bright-field imaging. Finally the embryo(s) with the highest EEVA grade are transferred were followed up until the achievement of implantation and confirmation of pregnancy.
Conventional incubatorDevice
The embryo culture of consented participants were carried out in conventional incubator for culture until Day 3 of embryo culture. On Day 3 of embryo culture, all embryos are assessed using a bench-top microscope. The embryo(s) with optimal cell stage and grade were transferred and were followed up until the achievement of implantation and confirmation of pregnancy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical Pregnancy Rate With Positive Fetal Heart Beat (FHB)Time frame: Gestation Weeks 6 to 8
Locations
17 sites in 7 countries. Site status is shown where the registry gives one.
Cambrian Wellness Centre
Calgary, Canada
Regional Fertility Program
Calgary, Canada
Skive Fertility clinic
Skive, Denmark
14 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.